lx2006
·Code: LX2006
lx2006: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | Phase 2 |
FDA Decisions
FDA_MeetingFDA indicated openness to a BLA submission for accelerated approval using pooled clinical data, provided enhanced manufacturing comparability data and nonclinical requirements are met.(LXEO)
Frequently asked questions
Who is developing lx2006?
lx2006 is being developed by Lexeo Therapeutics, Inc..
What is lx2006's latest FDA decision?
The most recent tracked FDA decision for lx2006 is FDA_Meeting for FDA indicated openness to a BLA submission for accelerated approval using pooled clinical data, provided enhanced manufacturing comparability data and nonclinical requirements are met..
Get deeper analysis on lx2006
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis